Advertisement
Screener

ImmuCell Corporation (ICCC) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Research and Development Expense

ImmuCell Corporation (ICCC) reported Research and Development Expense of $119.65 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13

  • ImmuCell Corporation research and development expense for the quarter ending 2026-06-30 was $119.65K, a 85.62% decline year-over-year.
  • ImmuCell Corporation research and development expense for the quarter ending 2026-03-31 was $317.69K, a 58.02% decline year-over-year.
  • ImmuCell Corporation research and development expense for the quarter ending 2025-12-31 was $758.86K, a 7.39% decline year-over-year.
  • ImmuCell Corporation research and development expense for the quarter ending 2025-09-30 was $694.31K, a 11.68% decline year-over-year.
  • ImmuCell Corporation research and development expense for fiscal 2025 was $3.04M, a 21.97% decline from fiscal 2024.
  • ImmuCell Corporation research and development expense for fiscal 2024 was $3.90M, a 11.29% decline from fiscal 2023.
  • ImmuCell Corporation research and development expense for fiscal 2023 was $4.39M, a 2.20% decline from fiscal 2022.
  • ImmuCell Corporation research and development expense for fiscal 2022 was $4.49M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 month
2026-06-30$119.65K
10-Q · filed 2026-08-13
$437.34K
10-Q · filed 2026-08-13
$1.20M
derived: sum of 3 quarters · filed 2026-08-13
$1.89M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$317.69K
10-Q · filed 2026-05-14
$1.08M
derived: sum of 2 quarters · filed 2026-05-14
$1.77M
derived: sum of 3 quarters · filed 2026-05-14
$2.60M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$758.86K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$1.45M
derived: sum of 2 quarters · filed 2026-03-30
$2.29M
derived: sum of 3 quarters · filed 2026-08-13
$3.04M
10-K · filed 2026-03-30
2025-09-30$694.31K
10-Q · filed 2025-11-13
$1.53M
derived: sum of 2 quarters · filed 2026-08-13
$2.28M
10-Q · filed 2025-11-13
$3.10M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$831.86K
10-Q · filed 2026-08-13
$1.59M
10-Q · filed 2026-08-13
$2.41M
derived: sum of 3 quarters · filed 2026-08-13
$3.19M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$756.85K
10-Q · filed 2026-05-14
$1.58M
derived: sum of 2 quarters · filed 2026-05-14
$2.36M
derived: sum of 3 quarters · filed 2026-05-14
$3.39M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$819.39K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$1.61M
derived: sum of 2 quarters · filed 2026-03-30
$2.64M
derived: sum of 3 quarters · filed 2026-03-30
$3.90M
10-K · filed 2026-03-30
2024-09-30$786.14K
10-Q · filed 2025-11-13
$1.82M
derived: sum of 2 quarters · filed 2025-11-13
$3.08M
10-Q · filed 2025-11-13
$3.08M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.03M
10-Q · filed 2025-08-14
$2.29M
10-Q · filed 2025-08-14
$2.29M
derived: sum of 3 quarters · filed 2025-08-14
$3.41M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.26M
10-Q · filed 2025-05-14
$1.26M
derived: sum of 2 quarters · filed 2025-05-14
$2.38M
derived: sum of 3 quarters · filed 2025-05-14
$3.48M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
$1.12M
derived: sum of 2 quarters · filed 2025-03-28
$2.22M
derived: sum of 3 quarters · filed 2025-03-28
$4.39M
10-K · filed 2025-03-28
2023-09-30$1.12M
10-Q · filed 2024-11-13
$2.22M
derived: sum of 2 quarters · filed 2024-11-13
$4.39M
10-Q · filed 2025-11-13
$3.33M
10-Q · filed 2023-11-13
$4.38M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$1.10M
10-Q · filed 2024-08-13
$2.21M
10-Q · filed 2024-08-13
$3.26M
derived: sum of 3 quarters · filed 2024-08-13
$4.53M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$1.11M
10-Q · filed 2024-05-14
$2.16M
derived: sum of 2 quarters · filed 2024-05-14
$3.43M
derived: sum of 3 quarters · filed 2024-05-14
$4.57M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$2.32M
derived: sum of 2 quarters · filed 2024-04-01
$3.46M
derived: sum of 3 quarters · filed 2024-04-01
$4.49M
10-K · filed 2024-04-01
2022-09-30$1.27M
10-Q · filed 2023-11-13
$2.41M
derived: sum of 2 quarters · filed 2023-11-13
$3.44M
10-Q · filed 2023-11-13
$4.53M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$1.14M
10-Q · filed 2023-08-10
$2.17M
10-Q · filed 2023-08-10
$3.26M
derived: sum of 3 quarters · filed 2023-11-13
$4.31M
derived: sum of 4 quarters · filed 2023-11-13
2022-03-31$1.04M
10-Q · filed 2023-05-11
$2.13M
derived: sum of 2 quarters · filed 2023-11-13
$3.17M
derived: sum of 3 quarters · filed 2023-11-13
$4.17M
derived: sum of 4 quarters · filed 2023-11-13
2021-12-31$1.09M
derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-13
$2.14M
derived: sum of 2 quarters · filed 2023-11-13
$3.14M
derived: sum of 3 quarters · filed 2023-11-13
$4.17M
10-Q · filed 2023-11-13
2021-09-30$1.05M
10-Q · filed 2022-11-21
$2.05M
derived: sum of 2 quarters · filed 2022-11-21
$3.08M
10-Q · filed 2022-11-21
$4.25M
derived: sum of 4 quarters · filed 2022-11-21
2021-06-30$1.00M
10-Q/A · filed 2022-11-21
$2.03M
10-Q/A · filed 2022-11-21
$3.20M
derived: sum of 3 quarters · filed 2022-11-21
$4.32M
derived: sum of 4 quarters · filed 2022-11-21
2021-03-31$1.03M
10-Q/A · filed 2022-11-21
$2.20M
derived: sum of 2 quarters · filed 2022-11-21
$3.32M
derived: sum of 3 quarters · filed 2022-11-21
$4.41M
derived: sum of 4 quarters · filed 2022-11-21
2020-12-31$1.17M
derived: 10-Q/A 12 month − 10-Q 9 month · filed 2022-11-21
$2.29M
derived: sum of 2 quarters · filed 2022-11-21
$3.38M
derived: sum of 3 quarters · filed 2022-11-21
$4.35M
10-Q/A · filed 2022-11-21
2020-09-30$1.12M
10-Q · filed 2021-11-15
$2.21M
derived: sum of 2 quarters · filed 2021-11-15
$3.18M
10-Q · filed 2021-11-15
$4.16M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$1.09M
10-Q · filed 2021-08-12
$2.06M
10-Q · filed 2021-08-12
$3.03M
derived: sum of 3 quarters · filed 2021-08-12
$4.02M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$974.43K
10-Q · filed 2021-05-13
$1.95M
derived: sum of 2 quarters · filed 2021-05-13
$2.93M
derived: sum of 3 quarters · filed 2021-05-13
$3.75M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$972.46K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$1.96M
derived: sum of 2 quarters · filed 2021-03-30
$2.78M
derived: sum of 3 quarters · filed 2021-03-30
$3.69M
10-K · filed 2021-03-30
2019-09-30$984.73K
10-Q · filed 2020-11-12
$1.80M
derived: sum of 2 quarters · filed 2020-11-12
$2.72M
10-Q · filed 2020-11-12
$3.98M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$820.05K
10-Q · filed 2020-08-12
$1.73M
10-Q · filed 2020-08-12
$2.99M
derived: sum of 3 quarters · filed 2020-08-12
$3.90M
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$910.37K
10-Q · filed 2020-05-13
$2.17M
derived: sum of 2 quarters · filed 2020-05-13
$3.08M
derived: sum of 3 quarters · filed 2020-05-13
$3.84M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
$2.17M
derived: sum of 2 quarters · filed 2020-03-27
$2.93M
derived: sum of 3 quarters · filed 2020-03-27
$3.52M
10-K · filed 2020-03-27
2018-09-30$908.79K
10-Q · filed 2019-11-12
$1.67M
derived: sum of 2 quarters · filed 2019-11-12
$2.25M
10-Q · filed 2019-11-12
$2.99M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$761.89K
10-Q · filed 2019-08-12
$1.34M
10-Q · filed 2019-08-12
$2.08M
derived: sum of 3 quarters · filed 2019-08-12
$2.66M
derived: sum of 4 quarters · filed 2019-08-12
2018-03-31$582.93K
10-Q · filed 2019-05-13
$1.32M
derived: sum of 2 quarters · filed 2019-05-13
$1.90M
derived: sum of 3 quarters · filed 2019-05-13
$2.29M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31$734.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
$1.32M
derived: sum of 2 quarters · filed 2019-03-22
$1.71M
derived: sum of 3 quarters · filed 2019-03-22
$2.05M
10-K · filed 2019-03-22
2017-09-30$585.83K
10-Q · filed 2018-11-13
$972.84K
derived: sum of 2 quarters · filed 2018-11-13
$1.31M
10-Q · filed 2018-11-13
$1.57M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$387.01K
10-Q · filed 2018-08-13
$726.62K
10-Q · filed 2018-08-13
$980.36K
derived: sum of 3 quarters · filed 2018-08-13
$1.29M
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31$339.62K
10-Q · filed 2018-05-14
$593.35K
derived: sum of 2 quarters · filed 2018-05-14
$901.07K
derived: sum of 3 quarters · filed 2018-05-14
$1.28M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$253.74K
10-K · filed 2017-03-30
$561.46K
derived: sum of 2 quarters · filed 2017-11-13
$941.89K
derived: sum of 3 quarters · filed 2017-11-13
$1.24M
10-K · filed 2018-03-29
2016-09-30$307.72K
10-Q · filed 2017-11-13
$688.15K
derived: sum of 2 quarters · filed 2017-11-13
$990.60K
10-Q · filed 2017-11-13
$1.32M
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30$380.43K
10-Q · filed 2017-08-14
$682.88K
10-Q · filed 2017-08-14
$1.01M
derived: sum of 3 quarters · filed 2017-08-14
$1.32M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$302.44K
10-Q · filed 2017-05-11
$633.58K
derived: sum of 2 quarters · filed 2017-05-11
$935.33K
derived: sum of 3 quarters · filed 2017-05-11
$1.21M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$331.14K
10-K · filed 2017-03-30
$632.88K
derived: sum of 2 quarters · filed 2017-03-30
$904.64K
derived: sum of 3 quarters · filed 2017-03-30
$1.24M
10-K · filed 2017-03-30
2015-09-30$301.75K
10-K · filed 2017-03-30
$573.50K
derived: sum of 2 quarters · filed 2017-03-30
$904.17K
10-Q · filed 2016-11-10
$1.37M
derived: sum of 4 quarters · filed 2017-03-30
2015-06-30$271.76K
10-K · filed 2017-03-30
$602.42K
10-Q · filed 2016-08-11
$1.07M
derived: sum of 3 quarters · filed 2017-03-30
$1.43M
derived: sum of 4 quarters · filed 2017-03-30
2015-03-31$330.67K
10-K · filed 2017-03-30
$793.63K
derived: sum of 2 quarters · filed 2017-03-30
$1.15M
derived: sum of 3 quarters · filed 2017-03-30
$1.92M
derived: sum of 4 quarters · filed 2017-03-30
2014-12-31$462.96K
10-K · filed 2016-03-25
$824.20K
derived: sum of 2 quarters · filed 2016-03-25
$1.58M
derived: sum of 3 quarters · filed 2016-03-25
$2.18M
10-K · filed 2016-03-25
2014-09-30$361.23K
10-K · filed 2016-03-25
$1.12M
derived: sum of 2 quarters · filed 2016-03-25
$1.72M
10-Q · filed 2015-11-12
$2.04M
derived: sum of 4 quarters · filed 2016-03-25
2014-06-30$760.67K
10-K · filed 2016-03-25
$1.35M
10-Q · filed 2015-08-13
$1.68M
derived: sum of 3 quarters · filed 2016-03-25
$1.97M
derived: sum of 4 quarters · filed 2016-03-25
2014-03-31$594.21K
10-K · filed 2016-03-25
$919.22K
derived: sum of 2 quarters · filed 2016-03-25
$1.21M
derived: sum of 3 quarters · filed 2016-03-25
$1.48M
derived: sum of 4 quarters · filed 2016-03-25
2013-12-31$325.01K
10-K · filed 2016-03-25
$615.86K
derived: sum of 2 quarters · filed 2016-03-25
$887.72K
derived: sum of 3 quarters · filed 2016-03-25
$1.15M
10-K · filed 2016-03-25
2013-09-30$290.85K
10-K · filed 2016-03-25
$562.71K
derived: sum of 2 quarters · filed 2016-03-25
$829.19K
10-Q · filed 2014-11-12
$1.06M
derived: sum of 4 quarters · filed 2016-03-25
2013-06-30$271.86K
10-K · filed 2016-03-25
$538.34K
10-Q · filed 2014-08-13
$772.65K
derived: sum of 3 quarters · filed 2016-03-25
$996.42K
derived: sum of 4 quarters · filed 2016-03-25
2013-03-31$266.48K
10-K · filed 2016-03-25
$500.80K
derived: sum of 2 quarters · filed 2016-03-25
$724.57K
derived: sum of 3 quarters · filed 2016-03-25
$936.27K
derived: sum of 4 quarters · filed 2016-03-25
2012-12-31$234.32K
10-K · filed 2015-03-26
$458.09K
derived: sum of 2 quarters · filed 2015-03-26
$669.79K
derived: sum of 3 quarters · filed 2015-03-26
$917.60K
10-K · filed 2015-03-26
2012-09-30$223.77K
10-K · filed 2015-03-26
$435.48K
derived: sum of 2 quarters · filed 2015-03-26
$683.28K
10-Q · filed 2013-11-13
$954.36K
derived: sum of 4 quarters · filed 2015-03-26
2012-06-30$211.71K
10-K · filed 2015-03-26
$459.51K
10-Q · filed 2013-08-13
$730.59K
derived: sum of 3 quarters · filed 2015-03-26
$1.03M
derived: sum of 4 quarters · filed 2015-03-26
2012-03-31$247.81K
10-K · filed 2015-03-26
$518.88K
derived: sum of 2 quarters · filed 2015-03-26
$822.97K
derived: sum of 3 quarters · filed 2015-03-26
$1.50M
derived: sum of 4 quarters · filed 2015-03-26
2011-12-31$271.08K
10-K · filed 2014-03-26
$575.16K
derived: sum of 2 quarters · filed 2014-03-26
$1.25M
derived: sum of 3 quarters · filed 2014-03-26
$1.72M
10-K · filed 2014-03-26
2011-09-30$304.08K
10-K · filed 2014-03-26
$976.85K
derived: sum of 2 quarters · filed 2014-03-26
$1.45M
10-Q · filed 2012-11-13
$1.89M
derived: sum of 4 quarters · filed 2014-03-26
2011-06-30$672.76K
10-K · filed 2014-03-26
$1.14M
10-Q/A · filed 2012-09-07
$1.59M
derived: sum of 3 quarters · filed 2014-03-26
$1.90M
derived: sum of 4 quarters · filed 2014-03-26
2011-03-31$472.13K
10-K · filed 2014-03-26
$914.00K
derived: sum of 2 quarters · filed 2014-03-26
$1.23M
derived: sum of 3 quarters · filed 2014-03-26
$1.56M
derived: sum of 4 quarters · filed 2014-03-26
2010-12-31$441.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$754.02K
derived: sum of 2 quarters · filed 2013-03-28
$1.09M
derived: sum of 3 quarters · filed 2013-03-28
$1.49M
10-K · filed 2013-03-28
2010-09-30$312.16K
10-Q · filed 2011-11-14
$645.48K
derived: sum of 2 quarters · filed 2011-11-14
$1.05M
10-Q · filed 2011-11-14
2010-06-30$333.32K
10-Q · filed 2011-08-15
$738.78K
10-Q · filed 2011-08-15
2009-12-31$1.64M
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92